DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $302,869,587 | -30.9% | 14,681,027 | -1.1% | 0.28% | -25.8% |
Q2 2023 | $438,039,653 | +23.8% | 14,843,770 | -3.3% | 0.37% | +16.6% |
Q1 2023 | $353,712,637 | -15.9% | 15,352,111 | +1.5% | 0.32% | -27.2% |
Q4 2022 | $420,472,572 | -6.9% | 15,119,474 | +2.7% | 0.44% | -6.0% |
Q3 2022 | $451,605,000 | +3.2% | 14,715,051 | -1.0% | 0.47% | +3.8% |
Q2 2022 | $437,606,000 | -9.2% | 14,869,374 | -0.7% | 0.45% | +32.8% |
Q1 2022 | $481,921,000 | -28.2% | 14,980,432 | -0.5% | 0.34% | -8.2% |
Q4 2021 | $671,515,000 | -11.3% | 15,056,381 | +0.3% | 0.37% | -7.1% |
Q3 2021 | $757,245,000 | -36.3% | 15,009,816 | -0.9% | 0.40% | -31.6% |
Q2 2021 | $1,188,179,000 | +60.1% | 15,147,613 | +16.6% | 0.58% | +39.5% |
Q1 2021 | $742,026,000 | -27.3% | 12,995,197 | +6.6% | 0.42% | -26.9% |
Q4 2020 | $1,021,056,000 | +163.2% | 12,190,256 | +12.6% | 0.57% | +112.7% |
Q3 2020 | $387,938,000 | +72.9% | 10,827,178 | +16.7% | 0.27% | +56.1% |
Q2 2020 | $224,371,000 | +40.4% | 9,279,194 | +1.6% | 0.17% | -1.2% |
Q1 2020 | $159,861,000 | +20.9% | 9,129,752 | +20.3% | 0.17% | +35.2% |
Q4 2019 | $132,221,000 | +17.2% | 7,590,247 | +3.1% | 0.13% | 0.0% |
Q3 2019 | $112,809,000 | -26.6% | 7,363,463 | -0.6% | 0.13% | -21.5% |
Q2 2019 | $153,773,000 | +5.8% | 7,407,229 | +18.3% | 0.16% | +2.5% |
Q1 2019 | $145,408,000 | +13.0% | 6,262,226 | +0.6% | 0.16% | -4.8% |
Q4 2018 | $128,665,000 | +7.9% | 6,227,724 | +13.5% | 0.17% | +29.5% |
Q3 2018 | $119,275,000 | +46.3% | 5,486,421 | +2.7% | 0.13% | +46.6% |
Q2 2018 | $81,506,000 | -20.3% | 5,344,633 | +2.9% | 0.09% | -26.7% |
Q1 2018 | $102,247,000 | +32.8% | 5,192,846 | +5.5% | 0.12% | +25.0% |
Q4 2017 | $76,976,000 | – | 4,921,783 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |